While AFP is widely recognized as a tumor marker for hepatocellular carcinoma and germ cell tumors, emerging evidence suggests its relevance in gastric cancer, particularly in a rare subtype known as AFP-producing gastric cancer (AFPGC). This evidence concerns the gene AFP and hepatocellular carcinoma.